menu
    • menu

    Company profile for Protagonist Therapeutics

    NEW Drugs in Dev: 9
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. We have successfully utilized the platform to date to identify oral, GI-restricted peptides (PTG-100 and PTG-200) for inflammatory bowel diseases (IBD) ...
    a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. We have successfully utilized the platform to date to identify oral, GI-restricted peptides (PTG-100 and PTG-200) for inflammatory bowel diseases (IBD) and injectable peptides (PTG-300) for rare blood disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Protagonist TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7707 Gateway Boulevard, Suite 140 Newark, CA 94560-1160 USA
    Telephone
    Telephone
    +1 510 474 0170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.protagonist-inc.com/home-page/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/protagonist-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Protagonist Therapeutics to Attend 44th JPM Healthcare Conference
    Protagonist Therapeutics to Attend 44th JPM Healthcare Conference

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/protagonist-therapeutics-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-2026

    PHARMIWEB
    07 Jan 2026
    Share Share
    Takeda, Protagonist Submit Rusfertide (NDA) For Polycythemia Vera
    Takeda, Protagonist Submit Rusfertide (NDA) For Polycythemia Vera

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260101831438/en/Takeda-and-Protagonist-Announce-Submission-of-New-Drug-Application-NDA-for-Rusfertide-for-Treatment-of-Polycythemia-Vera-PV

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Protagonist, Takeda Present Rusfertide PV Data at ASH 2025
    Protagonist, Takeda Present Rusfertide PV Data at ASH 2025

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251205962286/en/Protagonist-and-Takeda-Present-Longer-Term-Data-at-ASH-2025-Showing-Rusfertide-Delivers-Durable-Response-and-Hematocrit-Control-in-Polycythemia-Vera

    BUSINESSWIRE
    06 Dec 2025
    Share Share
    Protagonist Reveals Q3 2025 Financials & Corporate Update
    Protagonist Reveals Q3 2025 Financials & Corporate Update

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/protagonist-reports-third-quarter-2025-financial-results-and-provides-corporate-update

    PHARMIWEB
    06 Nov 2025
    Share Share
    Protagonist Therapeutics Presents Rusfertide at ASH Meeting
    Protagonist Therapeutics Presents Rusfertide at ASH Meeting

    03 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-03/protagonist-therapeutics-announces-oral-and-poster-presentations-on-rusfertide-at-the-67th-annual-as

    PHARMIWEB
    03 Nov 2025
    Share Share
    Protagonist's Icotrokinra Data in Ulcerative Colitis & Psoriasis
    Protagonist's Icotrokinra Data in Ulcerative Colitis & Psoriasis

    27 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-27/protagonist-announces-new-icotrokinra-data-in-ulcerative-colitis-and-plaque-psoriasis-presented-at-t

    PHARMIWEB
    27 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search